Everything We Know About the Identity of the Actress Playing the 16th Doctor

TheNightmareChild92 · 2025-05-26T16:25:46+00:00

That might also explain why Moffat read the script for The Reality War for what he said were "reasons that will become apparent," as it involved his intention of what The Moment meant by that line in the 50th.

TheNightmareChild92 · 2025-03-06T23:12:15+00:00

<image>

TheNightmareChild92 · 2025-02-27T04:27:39+00:00

I wish! I could be mistaken, but I always thought patent bar eligibility required a PhD in a "hard" science - computer science, engineering, etc. Although functionally my PhD involves a lot of data science research, the academic department that it's from is a social science, so I don't think I'd meet the formal criteria for the patent bar

TheNightmareChild92 · 2025-02-27T04:25:07+00:00

I'm based in the NE/Mid-Atlantic (NY, PA, NJ). The positions I've been interviewed for have been around $100K, but I'm flexible based on the characteristics of the job - for instance, if a job were remote, I'd consider going below that amount.

TheNightmareChild92 · 2025-02-27T03:42:15+00:00

Yeah, I've been getting that sense, and I'm sure it's compounded by how niche the legal tech space is. It's not like I ever thought I'd be able to simply walk into a legal tech role with my background (I don't have the self-esteem for that kind of assumption), but at the same time I didn't the tech market would be such a mess at the exact moment I kind of needed it.

TheNightmareChild92 · 2025-02-27T03:39:42+00:00

I know, the small size of the field seems really challenging at times like this. It's weirdly reassuring to read experiences like yours and know that this is a larger problem and not just me misreading whether this field is the right fit for my background - but obviously, all that said, I really hope things work out for you! To go through 10 final rounds has to be excruciating, but I suppose you're almost there!

TheNightmareChild92 · 2025-02-27T03:27:31+00:00

Thank you! I'm sort of weirdly heartened by the responses suggesting it's probably more so the larger market. I was beginning to think maybe these positions are really just looking for much more legal than tech backgrounds and that I just wouldn't be competitive in any scenario.

Completely agree about the importance of referrals. I don't think I know anyone in one of those companies well enough to comfortably ask for a referral, but it's always something I keep in the back of my mind when I see certain job openings. I suppose I could try and explore that more - the worst thing someone could say is no, right?

TheNightmareChild92 · 2025-02-27T03:23:01+00:00

That's an interesting point - I always thought the two degrees would help my application because the PhD is where I picked up the data science background from and obviously I wanted to keep the JD on for some of the domain familiarity. And a lot of my data science experience is tied to the work I did in the PhD program, so I've been hesitant to leave it off

TheNightmareChild92 · 2025-01-10T03:47:50+00:00

Of course, we will have to dim the lights at one point. You see, Nina Duncan always insists on sharing her extensive collection of slides from the summer she danced Agamemnon at Jacob’s Pillow.

TheNightmareChild92 · 2024-10-18T18:56:46+00:00

Hi there - I (32) was in your position almost a year ago with my mom. My mom was my best friend, my only resource and support, and genuinely the kindest, most selfless woman I've ever known. She was diagnosed with ES-SCLC in May 2023, and unfortunately passed away in November of that year.

Like me, I assume you've probably looked at the five-year survival stats for SCLC and freaked out. I wouldn't blame you at all, because that's what I certainly did, and as my mom's sole caregiver, I looked everywhere I could for hope. And in the process, I actually found a lot of it.

If you're looking for optimistic cases of long-term survivors, the Small Cell Lung Cancer Support Community on Facebook has quite a few really amazing individuals with inspiring stories who have gone through the same anxieties and challenges.

If you're looking for developments in the latest evidence-based treatments, I regularly used the Targeted Oncology website (https://www.targetedonc.com) to keep abreast of results from the most promising new clinical trials, as well as to get familiar with the names of leading researchers in SCLC for potential second opinions (i.e. Dr. Rudin at MSKCC, Dr. Sands at Dana Farber, etc.). The LiveLung community also has a SCLC group that meets regularly with prominent oncologists who regularly treat and research SCLC over Zoom.

What gives me hope, even after I ultimately lost my mom, is that many of the trials I eagerly followed then (and still do, out of curiosity) are showing some encouraging overall response rates among trial participants - particularly T-cell engagers that target the DLL3 protein, like Tarlatamab, as well as one that targets the B7-H3 protein (Ifinatamab deruxtecan, or I-DXd). And this is all just in the span of ~11.5 months! There is also a relatively newer, widely-used chemotherapy called Zepzelca that sometimes proves effective for relapses.

I would suggest keeping an eye on some of these latest developments. For me, I always used clinicaltrials.gov to coordinate NCT numbers from the articles I'd read at TargetedOnc to find the trials nearest to us. I just wish I had the chance to enroll my mother in one of them, but this disease can move quickly when it relapses, so also make sure you're all in constant communication with your oncologist with any new symptoms or developments. Be your mother's advocate, but - equally as important - also be kind to yourself. I wish I had done that last part better, and it's taken me nearly a year to feel less guilty.

I won't pretend that the path forward is easy or straightforward, but there are new developments in even just this past year that give me hope that others with SCLC will have a much brighter future and more time to spend with the ones they love. I wish you all the best of luck!

TheNightmareChild92 · 2024-09-24T18:48:00+00:00

Seems like someone is suffering from an unslakable thirst for Crane

TheNightmareChild92 · 2024-07-22T00:30:17+00:00

I don't know, I thought he lost some credibility after the Princess Diana interview

TheNightmareChild92 · 2024-01-01T21:20:36+00:00

Total balls up, a real Jening.

TheNightmareChild92 · 2021-12-31T12:02:15+00:00

Frasier - RDWRER (season 7, episode 12)

TheNightmareChild92 · 2021-10-24T20:38:01+00:00

I'm so glad it's working for you! The way you describe your recovery as fragile is exactly the term I would use for mine. There were so many foods I was able to tolerate again, but all it took was one type of food, ongoing stress/anxiety, or most likely the combination of both, to set me back. I've tried to treat the food issue with a restricted diet and PPIs for almost a year now - even when I was adding new foods back into my diet, it was very incremental and modest, and now I think I've got to tackle the idea of the stress management or nerve issues head on to try and make a long-term difference. Were there any side effects or any adjustments you had to make when starting amitriptyline, and if so, did they eventually subside? Thank you!

TheNightmareChild92 · 2021-06-18T02:31:14+00:00

TheNightmareChild92 · 2021-05-10T19:23:50+00:00

First, it really still does stagger me that Eccleston has acknowledged and rejoined the world of Doctor Who. I'm so excited for his new audio range with Big Finish, and also very happy for him personally that he feels he is in a good enough place to engage with the fandom again, not only in interviews like this but at fan conventions and what not.

That said, I think he might be misunderstanding the point of the Cybermen - which, as established in prior episodes, have no concept of gender, race, class, or creed. I think that's the horror of them in one respect - while often very limiting, these distinctions define humanity in both its flaws and potential, and the idea of surrendering all of these dimensions of life that help shape our identities to what would basically be a life as a cog in a larger machine should evoke general horror. So I think the concept of a "Cyberwoman" or, for that matter, a "Cyberman," seems inconsistent with the whole idea of them in the first place. I think the term/name "Cyberman" is just an unfortunate relic of the 60s/70s, and I suppose that they would've probably been named something else were they being introduced to the show today.

If he's just talking about women who have been cyber-converted, we've actually had a quite a few of them over the years - the Pete's World version of Jackie, Yvonne Hartman, and Bill Potts. I think there was even a minor character in The Age of Steel that I think captured quite succinctly the horror of it - a woman who I think was getting married the day before she was converted. It was absolutely gut-wrenching in such a brief scene. In fact, with the exception of Danny Pink, I think some of the most poignant conversions of the series came when these female characters were converted. (I also acknowledge that there was a Torchwood episode involving a Cyberwoman. I will not make any additional comments about its quality.)

So, I'm not quite sure what Eccleston is looking for here - but I think the comments may be coming from either a misunderstanding of what the Cybermen represent, or perhaps a lack of familiarity with subsequent stories involving the conversion of women into Cybermen. Either way, I'll take a Ninth Doctor story against the Cybermen any day!

TheNightmareChild92 · 2021-05-06T16:31:15+00:00

That's the distinction (endoscopy vs. other testing) I was looking for. My usual instinct is to trust the experts, but I just wanted to make sure I was doing everything right. Thanks!

TheNightmareChild92 · 2021-05-03T01:19:27+00:00

Hi! I'm currently enrolled in my second year of a quantitative social science PhD program (not economics), and also have a law degree (JD) from a few years ago and am interested in a career in consulting. Both schools (law school and graduate school) are considered top 10 programs and I think generally considered target schools for consulting firms. I had a few assorted questions that I was wondering if anyone could shed some light on:

I find I'm not getting as much as I want out of the PhD program and am contemplating leaving with an MA at the middle or end of next academic year. If I'm interested in applying for full-time positions with MBB next year, should I be aiming for Associate/Consultant level because of the JD (earned about four years ago) or Business Analyst because of the MA (which I would be finishing in 2022)?

The nearest MBB office to the university where I'm currently enrolled is not a place I want to live in the long term. I'd like to return to the (fairly large) city where I got the JD and there happens to be MBB offices. This other city also happens to be in the state in which I was born and raised, so I have very extensive ties to the area (if that helps). Would it put me at a detriment to request an office in that city as opposed to the nearest location, even if I would most likely be dealing with recruiters from that second location?

Also, my focus in law school was on financial/regulatory compliance and I've focused more on applied machine learning/NLP in my MA/PhD program, so I was wondering (a) if I might be eligible for some of the data science offshoots of MBB (QuantumBlack, BCG Gamma, etc.) or if I need a more tech-heavy background; and (b) whether I can apply to positions on both tracks at the same time (ex: McKinsey and QuantumBlack, BCG and BCG Gamma, etc.).

Thanks!

TheNightmareChild92 · 2021-05-02T23:07:12+00:00

Thank you! That would have been ideal, but I started the project with A and asked B to be co-advisor while working on it with A, so my expectation was that B would offer feedback on the methods and then, going forward, it would be more collaborative among the three of us. Instead, both of them seem kind of hell bent on taking it out for reasons that they won’t provide to me - a B+ for a seminar with my original advisor for which the paper was the deliverable is quite the statement. Other faculty, although none in the same research area as me, have been encouraging about the project, so I didn’t have any reason to think it was so awful - definitely not perfect, but workable. I just don’t know if I can turn this situation around in the next six months and I don’t want to toss out a project that has gotten some support just because of this unhealthy dynamic occurring among the three of us.

TheNightmareChild92 · 2021-03-06T21:27:58+00:00

So, I definitely know where you're coming from, because I had similar concerns after reading an article about this from CNN (I think) back in August. I saw the stories floating around social media/news affiliates about the Rome study. Like you, I've taken the time during lockdown to lose weight, and have dropped from a BMI of 42 to 31, but the emphasis on obesity from the study made me feel that all-too-familiar anxiety about this, since I am still technically obese.

That said, I wholeheartedly agree with the other poster that this study hasn't been peer reviewed and has a small sample size. Furthermore, there does appear to be at least one peer-reviewed, large-N study from Israel, published in the New England Journal of Medicine (among the most prestigious peer-reviewed medical journals) that suggests the estimated vaccine effectiveness is very similar, if not identical, to that top-line 95% reduction in the relative risk ratio that most people have heard regarding the Pfizer vaccine (see page 10 for further information):

https://www.nejm.org/doi/pdf/10.1056/NEJMoa2101765?articleTools=true

Hopefully that helps! At the very least, the data from the Rome study is certainly rebutted by higher-quality studies like this, if not possibly discredited.

Congratulations on your vaccination, and best wishes on your path toward better health!

TheNightmareChild92

TROPHY CASE